```markdown
# Treatment Adherence by Bipolar Disorder Patients

## Table 3. Major frustrations reported by BPD patients

| Characteristic                           | n (%) |
|------------------------------------------|-------|
| **Illness-related factors**              |       |
| Mood swings                              | 281 (66.4) |
| Depressions                              | 238 (56.3) |
| Others' perceptions/stigma               | 184 (43.5) |
| Problems with trust/relationships/social interactions | 171 (40.4) |
| Holding down a job                       | 152 (35.9) |
| Hospitalization                          | 118 (27.9) |
| Highs of mood                             | 115 (27.2) |
| Lack of information                      | 26 (6.15) |
| **Treatment-related factors**            |       |
| Taking medication every day              | 216 (51.1) |
| Medication side-effects                  | 170 (40.2) |
| Cost of treatment                        | 3 (0.71) |
| **Miscellaneous factors**                |       |
| Other                                    | 34 (8.04) |

Responding patients (N = 423; 98.6%) cited four major frustrations/person (1708/423).

## Physician assessments of treatment

When psychiatrists were asked to report improvements in treatments for BPD patients needed to increase acceptance and adherence to treatment, the most common response was the need for better mood-stabilization in 48.0% of their 429 patients. In addition, they identified freedom from weight-gain as important for treatment-acceptance among 29.1% of their patients, and improvement of treatment-unresponsive depression in 30.8%. They also estimated that at least 59.0% of their BPD patients had experienced adverse effects of psychotropic medications at some time in the past, that adverse effects were of current concern to 14.0% of patients (60/429), and were considered by their physicians to be severe in 15.0% (9/60) of that subgroup. Psychiatrists reported further that 30.5% of their 429 BPD patients had experienced weight-gain in association with current treatment, with substantial prevalence of hyperlipidemia (19.1%) and diabetes (8.62%) and identified these as problems of particular clinical concern.

## Univariate analyses of factors associated with treatment-nonadherence

We compared treatment-nonadherent with treatment-adherent patients on a list of factors identified in the PSF and PRF questionnaires, which yielded a total of 59 variables tentatively related to treatment adherence, based on initial univariate comparisons (p ≤ 0.10), and 43 significantly (p < 0.05) associated

---

Copyright © 2007 John Wiley & Sons, Ltd.

Hum. Psychopharmacol Clin Exp 2008; 23: 95–105.

DOI: 10.1002/hup
```